MedPath

Blefime

Brand Name: Blefime

Generic Name: Cefepime (As Hydrochloride)

Active
Registration Number

DRP-5876-01

Dosage Form

Powder for Injection (I.M./I.V.)

Issuance Date

March 31, 2023

Expiry Date

April 8, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 g
PackagingUSP type 1 clear glass vial w/ grey butyl rubber stopper x 10 mL (Box of l's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cefepime (As Hydrochloride)Active

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform